The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
Membrane lipid homeostasis in bacteria
Zhang, Y.-M., & Rock, C. O. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1839 · Cited by 1,393
Lipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340
Oppenheimer, N. J., & James, T. L. (1989) · Academic Press eBooks · Cited by 820
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Triclosan: Applications and safety
Bhargava, H. N., & Leonard, P. A. (1996) · American Journal of Infection Control · doi:10.1016/s0196-6553(96)90017-6 · Cited by 529
Efficient insertional mutagenesis in lactococci and other gram-positive bacteria
Maguin, E., Prévost, H., Ehrlich, S. D., & Gruss, A. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.3.931-935.1996 · Cited by 486
Self-citationBacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug Discovery
Campbell, J. W., & Cronan, J. E. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.305 · Cited by 479
Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease
Glaser, P., Rusniok, C., Buchrieser, C., Chevalier, F., Frangeul, L., Msadek, T., Zouine, M., Couvé, E., Lalioui, L., Poyart, C., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03126.x · Cited by 476
Self-citationDiscovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
Wang, J., Kodali, S., Lee, S. H., Galgoci, A., Painter, R., Dorso, K., Racine, F., Motyl, M., Hernandez, L., Tinney, E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700746104 · Cited by 381
Research works printed but not linked: 2
- Scortti, M. et al. Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox. Nature Med. 12, 515–517 (2006) · doi:10.1038/nm1396
- Gill, C. J. et al. In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345). Antimicrob. Agents Chemother. 42, 1996–2001 (1998) · doi:10.1128/aac.42.8.1996
Cited by
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Bacterial lipids: Metabolism and membrane homeostasis
Parsons, J. B., & Rock, C. O. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.02.002 · Cited by 528
Prospects for new antibiotics: a molecule-centered perspective
Walsh, C. T., & Wencewicz, T. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.49 · Cited by 372
Optical control of antibacterial activity
Velema, W. A., van der Berg, J. P., Hansen, M. J., Szymanski, W., Driessen, A. J. M., & Feringa, B. L. (2013) · Nature Chemistry · doi:10.1038/nchem.1750 · Cited by 371
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Ribeiro da Cunha, B., Fonseca, L. P., & Calado, C. R. C. (2019) · Antibiotics · doi:10.3390/antibiotics8020045 · Cited by 353
Current understanding of fatty acid biosynthesis and the acyl carrier protein
Chan, D. I., & Vogel, H. J. (2010) · Biochemical Journal · doi:10.1042/bj20100462 · Cited by 296
Pethe, K., Sequeira, P. C., Agarwalla, S., Rhee, K., Kuhen, K., Phong, W. Y., Patel, V., Beer, D., Walker, J. R., Duraiswamy, J., et al. (2010) · Nature Communications · doi:10.1038/ncomms1060 · Cited by 292
Parsons, J. B., Broussard, T. C., Bose, J. L., Rosch, J. W., Jackson, P., Subramanian, C., & Rock, C. O. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408797111 · Cited by 182
Systems-level antimicrobial drug and drug synergy discovery
Roemer, T., & Boone, C. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1205 · Cited by 159
Host Fatty Acid Utilization by Staphylococcus aureus at the Infection Site
Frank, M. W., Yao, J., Batte, J. L., Gullett, J. M., Subramanian, C., Rosch, J. W., & Rock, C. O. (2020) · mBio · doi:10.1128/mbio.00920-20 · Cited by 57
The double-edged role of FASII regulator FabT in Streptococcus pyogenes infection
Lambert, C., Gaillard, M., Wongdontree, P., Bachmann, C., Hautcoeur, A., Gloux, K., Guilbert, T., Méhats, C., Prost, B., Solgadi, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52637-3 · Cited by 8
Self-citation
Metadata
- Authors
- Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P., Gruss, A., & Poyart, C.
- Venue
- Nature
- Published
- 2009-03
- Volume
- 458
- Issue
- 7234
- Pages
- 83-86
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1987678916
- Cited by
- 317
- References
- 30
- FWCI
- 22.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.